Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
17 hedge funds and large institutions have $1.89M invested in Timber Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
13% more funds holding
Funds holding: 15 → 17 (+2)
15% less capital invested
Capital invested by funds: $2.23M → $1.89M (-$346K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$131K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65.9K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$64.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$145K |
| 2 |
VF
Virtu Financial
New York
|
-$21.7K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$18K |
| 4 |
BlackRock
New York
|
-$14.8K |
TMBR Hedge Fund Activity: Q3 2021 in Review
17 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q3 2021, worth a combined $1.89M — down 15% from $2.23M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TMBR positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $131K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $145K sold.
- 17 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q3 2021, up from 15 in Q2 2021.
- Funds reported $1.89M of Timber Pharmaceuticals, Inc. stock for Q3 2021, down 15% quarter-over-quarter.
- 4 funds opened new Timber Pharmaceuticals, Inc. positions in Q3 2021 and 2 closed out, a net change of +2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q3 2021 was Vanguard Group, an estimated $131K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q3 2021 was Renaissance Technologies, an estimated $145K sold.
Based on aggregated 13F filings for Q3 2021.